Literature DB >> 7930378

The plasma interleukin-6 and stress hormone responses to acute pyelonephritis.

R A Donald1, R R Bailey, D Hart, J H Livesey, M J Evans, L Mattioli, J Macdonald, A H Smith.   

Abstract

The relationships between the "stress hormones" corticotrophin (ACTH), vasopressin (AVP), corticotrophin releasing hormone (CRH) and cortisol, and the cytokines, interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor were studied during an acute infection. Ten patients (7 female, 3 male, age range 16-56 years) with acute pyelonephritis and normal renal function were studied during the first 72 hours following hospital admission. Peptide hormones were measured by radioimmunoassay, cortisol and cytokines by ELISA. Reference ranges for all hormones were from samples donated by 40 or more volunteers from the electoral roll. The reference data for IL-6 was obtained from 20 normal donor sera. The mean plasma IL-6, AVP and CRH concentrations on admission to hospital were significantly raised above the mean 08:00h values of the normal volunteers (p < 0.001 for AVP and CRH, p < 0.01 for IL-6), but mean plasma ACTH and cortisol were not. Mean plasma IL-6 and AVP were raised more than two standard deviations above the mean of the reference range for 72 hours, although IL-6 tended to fall after 24 hours. No change in plasma IL-1 and tumour necrosis factor was observed in three patients. The correlation between plasma IL-6 and cortisol concentrations at all sampling times and in all subjects was highly significant (p < 0.001). Significant correlations between plasma IL-6 and AVP (p < 0.005), and IL-6 and ACTH (p < 0.05) were also observed. No correlation between IL-6 and CRH could be demonstrated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930378     DOI: 10.1007/BF03348973

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Biphasic changes in hypothalamo-pituitary-adrenal function during the early recovery period after major abdominal surgery.

Authors:  Y Naito; J Fukata; S Tamai; N Seo; Y Nakai; K Mori; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1991-07       Impact factor: 5.958

2.  ACTH and vasopressin responses to insulin-induced hypoglycemia in intact and neurohypophysectomized conscious dogs.

Authors:  H Raff; P E Papanek; A W Cowley
Journal:  Neuroendocrinology       Date:  1991-01       Impact factor: 4.914

3.  Cytokines stimulate the CRH but not the vasopressin neuronal system: evidence for a median eminence site of interleukin-6 action.

Authors:  E Spinedi; R Hadid; T Daneva; R C Gaillard
Journal:  Neuroendocrinology       Date:  1992-07       Impact factor: 4.914

4.  An enzyme-linked immunosorbent assay (ELISA) for urinary free cortisol.

Authors:  J G Lewis; L Manley; J C Townsend; P A Elder
Journal:  Clin Chim Acta       Date:  1986-09-15       Impact factor: 3.786

5.  Serum levels of interleukin-6 and acute phase responses.

Authors:  M W Nijsten; E R de Groot; H J ten Duis; H J Klasen; C E Hack; L A Aarden
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

6.  Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats.

Authors:  Y Naitoh; J Fukata; T Tominaga; Y Nakai; S Tamai; K Mori; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1988-09-30       Impact factor: 3.575

7.  Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man.

Authors:  J J Staub; J S Jenkins; J G Ratcliffe; J Landon
Journal:  Br Med J       Date:  1973-02-03

8.  Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.

Authors:  R A Donald; I G Crozier; S G Foy; A M Richards; J H Livesey; M J Ellis; L Mattioli; H Ikram
Journal:  Clin Endocrinol (Oxf)       Date:  1994-04       Impact factor: 3.478

9.  Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.

Authors:  S Tsagarakis; G Kontogeorgos; P Giannou; N Thalassinos; J Woolley; G M Besser; A Grossman
Journal:  Clin Endocrinol (Oxf)       Date:  1992-08       Impact factor: 3.478

10.  Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release?

Authors:  H D Loxley; A M Cowell; R J Flower; J C Buckingham
Journal:  Neuroendocrinology       Date:  1993-05       Impact factor: 4.914

View more
  4 in total

1.  The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

Authors:  N N Spirin; D S Kasatkin
Journal:  Neurosci Behav Physiol       Date:  2009-01

2.  Urinary aquaporin-2 in children with acute pyelonephritis.

Authors:  Elena A Rodionova; Alla A Kuznetsova; Elena I Shakhmatova; Natalia Prutskova; Søren Nielsen; Ulla Holtbäck; Yuri Natochin; Marina Zelenina
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

Review 3.  Na(+), K(+), Cl(-), acid-base or H2O homeostasis in children with urinary tract infections: a narrative review.

Authors:  Anna Bertini; Gregorio P Milani; Giacomo D Simonetti; Emilio F Fossali; Pietro B Faré; Mario G Bianchetti; Sebastiano A G Lava
Journal:  Pediatr Nephrol       Date:  2015-12-23       Impact factor: 3.714

4.  Hormonal control of the renal immune response and antibacterial host defense by arginine vasopressin.

Authors:  Cécilia Chassin; Mathias W Hornef; Marcelle Bens; Michael Lotz; Jean-Michel Goujon; Sophie Vimont; Guillaume Arlet; Alexandre Hertig; Eric Rondeau; Alain Vandewalle
Journal:  J Exp Med       Date:  2007-10-29       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.